![]() | Up a level |
Mamounas, E. P.; Goldstein, L. J.; Penault-Llorca, F.; Roché, H.; Gluz, O.; Harbeck, N.; Nitz, U.; O'Shaughnessy, J.; Albain, K. S. (2017): Chemotherapy (CT) decision in node-positive (N plus ), ER plus , early breast cancer (EBC) after new ASCO Guideline - evidence for the 21-gene Recurrence Score (RS) assay. In: Breast, Vol. 32: S98-S98